Jump to:
PhosLo (calcium acetate) is a new phosphate binder available for the prevention and management of hyperphosphataemia in patients with advanced renal failure on dialysis.
The usual starting dose is two capsules with each meal, increasing until the desired phosphate level is achieved; most patients will require three or four capsules with each meal to achieve adequate control of phosphate levels.
Further information: Fresenius
There are currently no comments.
You must log in to comment on articles.
New users can register here free for full access.
Educational resource for the learning and teaching of the
GP curriculum
Cumulative list of products discontinued from the UK market
in 2010
Healthcare Republic resource centre for diagnosing and managing psoriasis
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
A Haymarket Publication © 1957 – 2010
